Table 6.
Correlation analyses for CEC and CDCH with “inflammation profile” components
| Characteristics | Healthy + at CAD risk + CAD (n = 45) |
Healthy + CKD G3–G5 (n = 47) |
||||||
|---|---|---|---|---|---|---|---|---|
| CEC |
CDCH |
CEC |
CDCH |
|||||
| r | P | r | P | r | P | r | P | |
| Inflammation | ||||||||
| hs-CRP, mg/l | −0.25 | 0.0913 | −0.40 | 0.0065 | 0.20 | 0.1793 | −0.23 | 0.1252 |
| Albumin, mg/dl | 0.24 | 0.1050 | 0.40 | 0.0070 | −0.49 | 0.0006 | 0.50 | 0.0005 |
| HbA1c, % | −0.34 | 0.0221 | −0.56 | <0.0001 | 0.42 | 0.0041 | −0.63 | <0.0001 |
CAD, coronary artery disease; CEC, cholesterol efflux capacity; CDCH, capacity to deliver cholesterol to hepatocytes; CKD, chronic kidney disease; hs-CRP, high-sensitivity C-reactive protein; HbA1c, hemoglobin A1c.
Correlation analysis is presented in terms of Spearman rank-based correlation coefficients r (significance level α = 0.05).